13F

Stock

Enliven Therapeutics, Inc.

ELVN · held by 1 managers

Reported value

$1.45M

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$170.9K

Price effect on 1 books still in the name

Largest holder

$1.45M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC64.6K$1.45M−$170.9KAdded$16.9K

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.